Literature DB >> 25670082

Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors.

Amy L Walz1, Ariadne Ooms2, Samantha Gadd3, Daniela S Gerhard4, Malcolm A Smith5, Jaime M Guidry Auvil, Jamie M Guidry Auvil4, Daoud Meerzaman6, Qing-Rong Chen6, Chih Hao Hsu6, Chunhua Yan6, Cu Nguyen6, Ying Hu6, Reanne Bowlby7, Denise Brooks7, Yussanne Ma7, Andrew J Mungall7, Richard A Moore7, Jacqueline Schein7, Marco A Marra8, Vicki Huff9, Jeffrey S Dome10, Yueh-Yun Chi11, Charles G Mullighan12, Jing Ma12, David A Wheeler13, Oliver A Hampton13, Nadereh Jafari14, Nicole Ross15, Julie M Gastier-Foster15, Elizabeth J Perlman16.   

Abstract

We report the most common single-nucleotide substitution/deletion mutations in favorable histology Wilms tumors (FHWTs) to occur within SIX1/2 (7% of 534 tumors) and microRNA processing genes (miRNAPGs) DGCR8 and DROSHA (15% of 534 tumors). Comprehensive analysis of 77 FHWTs indicates that tumors with SIX1/2 and/or miRNAPG mutations show a pre-induction metanephric mesenchyme gene expression pattern and are significantly associated with both perilobar nephrogenic rests and 11p15 imprinting aberrations. Significantly decreased expression of mature Let-7a and the miR-200 family (responsible for mesenchymal-to-epithelial transition) in miRNAPG mutant tumors is associated with an undifferentiated blastemal histology. The combination of SIX and miRNAPG mutations in the same tumor is associated with evidence of RAS activation and a higher rate of relapse and death.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25670082      PMCID: PMC4800737          DOI: 10.1016/j.ccell.2015.01.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  61 in total

1.  Computational techniques for human genome resequencing using mated gapped reads.

Authors:  Paolo Carnevali; Jonathan Baccash; Aaron L Halpern; Igor Nazarenko; Geoffrey B Nilsen; Krishna P Pant; Jessica C Ebert; Anushka Brownley; Matt Morenzoni; Vitali Karpinchyk; Bruce Martin; Dennis G Ballinger; Radoje Drmanac
Journal:  J Comput Biol       Date:  2011-12-16       Impact factor: 1.479

Review 2.  Wilms' tumour: connecting tumorigenesis and organ development in the kidney.

Authors:  Miguel N Rivera; Daniel A Haber
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

3.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

4.  Bambino: a variant detector and alignment viewer for next-generation sequencing data in the SAM/BAM format.

Authors:  Michael N Edmonson; Jinghui Zhang; Chunhua Yan; Richard P Finney; Daoud M Meerzaman; Kenneth H Buetow
Journal:  Bioinformatics       Date:  2011-01-28       Impact factor: 6.937

5.  Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital.

Authors:  Jeffrey S Dome; Tiebin Liu; Matthew Krasin; Lennie Lott; Patricia Shearer; Najat C Daw; Catherine A Billups; Judith A Wilimas
Journal:  J Pediatr Hematol Oncol       Date:  2002 Mar-Apr       Impact factor: 1.289

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 7.  Children's Oncology Group's 2013 blueprint for research: renal tumors.

Authors:  Jeffrey S Dome; Conrad V Fernandez; Elizabeth A Mullen; John A Kalapurakal; James I Geller; Vicki Huff; Eric J Gratias; David B Dix; Peter F Ehrlich; Geetika Khanna; Marcio H Malogolowkin; James R Anderson; Arlene Naranjo; Elizabeth J Perlman
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

8.  Using Drosophila melanogaster as a Model for Genotoxic Chemical Mutational Studies with a New Program, SnpSift.

Authors:  Pablo Cingolani; Viral M Patel; Melissa Coon; Tung Nguyen; Susan J Land; Douglas M Ruden; Xiangyi Lu
Journal:  Front Genet       Date:  2012-03-15       Impact factor: 4.599

9.  Lin28 promotes transformation and is associated with advanced human malignancies.

Authors:  Srinivas R Viswanathan; John T Powers; William Einhorn; Yujin Hoshida; Tony L Ng; Sara Toffanin; Maureen O'Sullivan; Jun Lu; Letha A Phillips; Victoria L Lockhart; Samar P Shah; Pradeep S Tanwar; Craig H Mermel; Rameen Beroukhim; Mohammad Azam; Jose Teixeira; Matthew Meyerson; Timothy P Hughes; Josep M Llovet; Jerald Radich; Charles G Mullighan; Todd R Golub; Poul H Sorensen; George Q Daley
Journal:  Nat Genet       Date:  2009-05-31       Impact factor: 38.330

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  104 in total

Review 1.  Dysregulation of microRNA biogenesis machinery in cancer.

Authors:  Akiko Hata; Risa Kashima
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-12-01       Impact factor: 8.250

Review 2.  Roles of microRNAs as non-invasive biomarker and therapeutic target in colorectal cancer.

Authors:  Timothy Ming-Hun Wan; Deepak Narayanan Iyer; Lui Ng
Journal:  Histol Histopathol       Date:  2019-10-16       Impact factor: 2.303

Review 3.  Genomics of adult and pediatric solid tumors.

Authors:  Zahraa Rahal; Farah Abdulhai; Humam Kadara; Raya Saab
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

4.  Ultrahigh thermal conductivity confirmed in boron arsenide.

Authors:  Chris Dames
Journal:  Science       Date:  2018-08-10       Impact factor: 47.728

5.  Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq.

Authors:  Hannah M Phelps; Mazin F Al-Jadiry; Natasha M Corbitt; Janene M Pierce; Bingshan Li; Qiang Wei; Raina R Flores; Hernan Correa; Stefania Uccini; Haydar Frangoul; Adel R Alsaadawi; Safaa A F Al-Badri; Amir F Al-Darraji; Raghad M Al-Saeed; Salma A Al-Hadad; Harold N Lovvorn Iii
Journal:  World J Pediatr       Date:  2018-08-28       Impact factor: 2.764

Review 6.  Non-coding RNAs: Epigenetic regulators of bone development and homeostasis.

Authors:  Mohammad Q Hassan; Coralee E Tye; Gary S Stein; Jane B Lian
Journal:  Bone       Date:  2015-05-31       Impact factor: 4.398

Review 7.  MicroRNA biogenesis pathways in cancer.

Authors:  Shuibin Lin; Richard I Gregory
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

8.  Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group.

Authors:  Eric J Gratias; Jeffrey S Dome; Lawrence J Jennings; Yueh-Yun Chi; Jing Tian; James Anderson; Paul Grundy; Elizabeth A Mullen; James I Geller; Conrad V Fernandez; Elizabeth J Perlman
Journal:  J Clin Oncol       Date:  2016-07-11       Impact factor: 44.544

9.  Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.

Authors:  Conrad V Fernandez; Elizabeth A Mullen; Yueh-Yun Chi; Peter F Ehrlich; Elizabeth J Perlman; John A Kalapurakal; Geetika Khanna; Arnold C Paulino; Thomas E Hamilton; Kenneth W Gow; Zelig Tochner; Fredric A Hoffer; Janice S Withycombe; Robert C Shamberger; Yeonil Kim; James I Geller; James R Anderson; Paul E Grundy; Jeffrey S Dome
Journal:  J Clin Oncol       Date:  2017-12-06       Impact factor: 44.544

10.  ClinGen Cancer Somatic Working Group - standardizing and democratizing access to cancer molecular diagnostic data to drive translational research.

Authors:  Subha Madhavan; Deborah Ritter; Christine Micheel; Shruti Rao; Angshumoy Roy; Dmitriy Sonkin; Matthew Mccoy; Malachi Griffith; Obi L Griffith; Peter Mcgarvey; Shashikant Kulkarni
Journal:  Pac Symp Biocomput       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.